Connect with us

General Health

Human Microbiome Market 2019 Future Scope Including Top key Osel Inc.,Vedanta Biosciences, Inc.,Metabiomics Corporate,Synthetic Biologics, Inc.

Published

on

Press Release

Human Microbiome Market to 2025 – Global Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography

The demand for healthcare facility has escalated the need for the rapid adoption of emerging technologies in the healthcare sector. The insight partners in their latest study on the human microbiome market revealed that the global human microbiome market is expected to grow at a CAGR of 21.8% for the period 2019 to 2025.

According to a new market research study titled ‘Human Microbiome Market to 2025 – Global Analysis and Forecasts by Product, Disease and Application. The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The report highlights the trends prevalent in the global human microbiome market and the factors driving the market along with those that act as deterrents to its growth.

Get Sample Copy At:-https://www.theinsightpartners.com/sample/TIPBT00002233/

The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.

The market for human microbiome is expected to grow as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing are expected to fuel the market growth during the forecast period. In addition, the human microbiome – a new frontier in drug discovery is likely to have a positive impact on the growth of the market in the coming years.

The major players operating in the human microbiome market:- Enterome, MicroBiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, and BiomX Ltd. For instance, in April 2018, MicroBiome Therapeutics, LLC (MBT), announced the launch of BiomeBliss, a patented, first-in-class prebiotic dietary supplement specifically developed to support a healthy gastrointestinal (GI) microbiome. Developed by pioneering researchers and entrepreneurs, BiomeBliss nourishes, shifts and protects the GI microbiome ? the trillions of gut bacteria that affect health. The developments performed by the companies are helping the market to grow in the coming years.

HUMAN MICROBIOME – MARKET SEGMENTATION

By Product

  • Probiotics
  • Foods
  • Prebiotics
  • Medical Foods
  • Diagnostic Device
  • Drugs
  • Supplements

By Disease

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
  • Others

By Application

  • Therapeutics
  • Diagnostics

TOC of Market Report Contains: –

  • Industry Overview
  • Production Market Analysis
  • Sales Market Analysis
  • Consumption Market Analysis
  • Production, Sales and Consumption Market Comparison Analysis
  • Major Manufacturers Production and Sales Market Comparison Analysis
  • Major Type of  Analysis
  • Major Organization Size Analysis
  • Industry Chain Analysis
  • Global and Regional Market Forecast
  • Major Manufacturers Analysis
  • New Project Investment Feasibility Analysis
  • And More…

Buy Report:-https://www.theinsightpartners.com/buy/TIPBT00002233/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: [email protected]/

Website: https://www.theinsightpartners.com/

This post was originally published on Health News Office

Continue Reading

General Health

Asia Pacific IVD Market Is Increasing Faster to Reach $19,888 Million and Predicted to Show Highest Growth Rates by 2023

Published

on

Asia Pacific IVD Market
Press Release

According to a new report published by Allied Market Research, titled, Asia Pacific IVD Market by Product Type, Techniques, Application and End-Users: Opportunity Analysis and Industry Forecast, 2017-2023, the Asia-Pacific IVD market was valued at $13,680 million in 2016, and is projected to reach at $19,888 million by 2023, growing at a CAGR of 5.4% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016.

Download PDF Report Sample @https://www.alliedmarketresearch.com/request-sample/1256

In vitro diagnostics (IVD) unlike most of the diagnostic tests, is performed on the samples from the body and do not involve contact with the patient, thereby reducing the risk of infections to the patients. Constant technological developments to improve efficacy of IVD, large pool of geriatric population, rise in incidence, and prevalence of communicable and non-communicable diseases, and increase in government healthcare expenditure in Asia-Pacific region drive the market growth. However, stringent government regulations related to the safety and efficacy of the IVD and unfavorable reimbursement policies are expected to restrain the market growth during the forecast period. Ongoing R&D associated with the IVD and increased disposable income of consumers provides huge growth potential for IVD market.

Based on product types, the reagents segment held the highest market share in 2016, owing to the recent introduction of new novel reagents in the market that are more effective.
Based on techniques, the immunodiagnostics segment contributed the highest market share in 2016, owing to the increase in prevalence of communicable and non-communicable diseases and rise in awareness of personalized medicine among the population.

Based on application, the infectious diseases segment contributed the highest market share in 2016, owing to the increase in prevalence of infectious diseases and rise in awareness of preventive health measures.

Based on end-users, the standalone laboratory segment captured the highest market share in 2016, mainly due to wide availability of complex tests and high-tech infrastructure enabling fast and accurate test results.

Make an Enquiry before Buying @

@https://www.alliedmarketresearch.com/purchase-enquiry/1256

Japan accounted for more than one-third share in 2016, and is expected to dominate the market throughout the forecast period and is attributed to increase in incidence of communicable and non-communicable diseases such as tuberculosis, diabetes, and cancer and rise in geriatric population, which is susceptible to these diseases and well-established healthcare systems. In addition, lucrative growth opportunities in the economic emerging countries is anticipated to provide new growth opportunities for the key players in the market. However, India is estimated to register the highest growth rate during the forecast period, owing to rise in government healthcare expenditure, increase in per capita income, growth in demand for healthcare devices from large pool of patient population, and improvement in healthcare infrastructure.

Key Findings of the Asia Pacific IVD Market:

  • The reagents segment dominated the market in 2016, and is projected to grow at the 4.4% CAGR.
  • The immunodiagnostics segment accounted for the highest share of two-ninths in 2016.
  • The infectious diseases segment holds a large market share in the Asia-Pacific IVD market by application 2016.
  • The standalone laboratory segment accounted for the highest share of two-ninths in 2016.
  • Japan was the major shareholder of Asia-Pacific IVD market in 2016.
  • India is expected to grow at the highest CAGR in the Asia-Pacific IVD market.

The major players profiled in the Asia-Pacific IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

Access Full Summary @https://www.alliedmarketresearch.com/asia-pacific-IVD-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.

Contact Us:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

Toll Free (USA/Canada):

+1-800-792-5285, +1-503-894-6022, +1-503-446-114

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1⟨855⟩550-5975

[email protected]

This post was originally published on Health News Office

Continue Reading

General Health

Enteral Feeding Devices Market to Perceive Significant Growth by 2025 with a CAGR over 5.4% from 2018 to 2025

Published

on

Enteral Feeding Devices Market
Press Release

According to a new report published by Allied Market Research, titled, Enteral Feeding Devices Market, by Product, Age Group, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025,” the global enteral feeding devices market was valued at $2,503 million in 2017, and is projected to reach $3,848 million by 2025 at a CAGR of 5.4% from 2018 to 2025.

Enteral feeding is nutritional therapy that provides nutrients directly to gastrointestinal tract in patients who cannot swallow food or who cannot get enough nourishment by eating or drinking. Enteral feeding therapy involves the usage of feeding devices such as pumps and tubes. These medical devices deliver the medications and nutrients directly into the stomach, duodenum, or jejunum via either the nose, mouth, or the direct percutaneous route.

Increase in prevalence of several chronic disorders such as cancer, neurological disorders across the world, upsurge in the adoption of enteral nutrition, rise in geriatric population, and growth in incidence of malnutrition cases drive the market. However, stringent governmental regulations and inadvertent dislodgment of tubes leading to accidental disabilities and deaths, impede the market growth. Conversely, the development of newer products with lesser side effects and presence of untapped market in the emerging economies are expected to provide lucrative growth opportunities for the market.

The enteral feeding pumps segment accounted for the largest share in 2017 owing to growth in usage and lesser side effects as compared to other devices. The enteral syringe segment is expected to grow at the high CAGR from 2018 to 2025.

The neurological disorder segment is the largest application segment in the global enteral feeding device market in 2017 and is estimated to grow at a moderate CAGR during the forecast period. On the other hand, the cancer segment is anticipated to record a highest CAGR during the forecast period.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/704

By age group, the adult segment dominated the global enteral feeding devices market in terms of revenue in 2017 and the trend is projected to continue throughout the forecast period.

The utilization rate of enteral feeding devices in hospitals is high owing to high availability of these products in hospitals and placement of tubes in hospitals with high success rate. However, the home care segment is expected to grow at a high CAGR during the forecast period.

Key findings of the Enteral Feeding Devices Market:

  • The enteral feeding tube segment accounted for nearly one-fifth share of the global enteral feeding devices market in 2017.
  • The pediatric segment is expected to grow at a CAGR of 6.5% from 2018 to 2025.
  • The gastrointestinal segment accounted for around one-eighth share of the global market in 2017.
  • North America accounted for around one-third share of the global market in 2017.
  • LAMEA is expected to provide lucrative market growth opportunities and grows with the CAGR of 6.0% from 2018 to 2025.

Europe was the leading revenue contributor to the global enteral feeding devices market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the early approval of enteral feeding devices and high adoption of enteral feeding pumps in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 6.6% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward safe enteral feedings products.

Make an Enquiry before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/704

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]

Web: https://www.alliedmarketresearch.com

 

This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Cancer Drugs Market 2019- Global Industry Analysis by Key Players, Share, Segmentation, Consumption, Growth, Trends and Forecast by 2021

Published

on

Press Release

Summary: –

Wiseguyreports.Com Adds “Cancer Drugs – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2021” To Its Research Database.

 

Overview:

The report covers forecast and analysis for the cancer drugs market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Billion). The study includes drivers and restraints for the cancer drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer drugs market on a global level.

The global Cancer Drugs market has been analyzed by market research experts and this study has been recently published in the report titled ‘Global Cancer Drugs market’. This report includes an analysis for a defined forecast period of 2019 to 2021.  The report has provided a basic overview at the beginning of the report to provide wider insight in the report, as the reader proceeds. This basic insight includes a brief overview regarding the product or service, along with a description of this product/service. The description also includes the primary and secondary applications of the product or service in surrounding industry verticals and the relationship between the growth of these industries and its impact on the growth of the global Cancer Drugs market.

 

Get Free Sample Report of Cancer Drugs Market@ https://www.wiseguyreports.com/sample-request/3195924-cancer-drugs-market-by-therapy-immunotherapy-targeted-therapy

 

Market Dynamics

The global Cancer Drugs market is studied for various dynamics in the market’s ecosystem that are influencing the growth trajectory, in both, a positive manner and a negative manner. These dynamics are the deciding factors in the path that the market is headed upon. These dynamics include the positive market drivers that are aiding the market to grow at its fullest potential. Further, the report also mentions various factors that are hindering such growth of the global Cancer Drugs market during the given forecast period.

The report has discussed some factors such as the rising prevalence of geriatric population, rising population all over the globe, the rising development of technology in all relevant industries. Apart from that, it has also discussed factors such as the advent of ground-breaking technologies such as robotics, the IoT, automation, and artificial intelligence. The report has explained the relationship between these developments of the business environment and the impact of the same on the market and the growth of the same.

 

Complete report with Comprehensive table of [email protected] https://www.wiseguyreports.com/reports/3195924-cancer-drugs-market-by-therapy-immunotherapy-targeted-therapy

 

Market Segmentation

The global Cancer Drugs market has been segmented on various aspects and examined for these specific segments to be able to reveal the hidden trends that are influencing the market’s functioning in the forthcoming years. The market’s regional segmentation has been conducted for North America, South America, Asia Pacific, the MEA, and Europe.

 

Research Methodology

The global Cancer Drugs market is analyzed using the Porter’s Five Force Model and a SWOT analysis has been conducted to aid market vendors with better understanding of the scenarios about to arise in the forecast period.

 

Key Players

Some prominent players are mentioned in the report titled ‘Global Cancer Drugs market’. The report has also mentioned various strategies that these vendors are bound to undertake for expansion.

 

Continued……………………

 

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

 

This post was originally published on Health News Office

Continue Reading

Trending